Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Addition of obinutuzumab or rituximab to chlorambucil improves outcomes for...

Dr Valentin Goede - University Hospital of Cologne, Germany

Addition of obinutuzumab or rituximab to chlorambucil improves outcomes for chronic lymphocytic leukaemia ( Dr Valentin Goede - University Hospital of Cologne, Germany )

Strategies to maintain remission in high risk CD19 lymphoid malignancies

Dr Partow Kebriaei - MD Anderson Cancer Center, Houston, USA

Strategies to maintain remission in high risk CD19 lymphoid malignancies ( Dr Partow Kebriaei - MD Anderson Cancer Center, Houston, USA )

Von Willebrand Factor and ADAMTS13

Dr Evan Sadler - Washington University in St Louis, USA

Von Willebrand Factor and ADAMTS13 ( Dr Evan Sadler - Washington University in St Louis, USA )

Use of autologous stem cell transplant in multiple myeloma

Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy

Use of autologous stem cell transplant in multiple myeloma ( Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy )

Study shows pomalidomide prolongs survival in refractory myeloma patients

Prof Jesus San Miguel - University Hospital of Salamanca, Salamanca, Spain

$Study shows pomalidomide prolongs survival in refractory myeloma patients ( Prof Jesus San Miguel - University Hospital of Salamanca, Salamanca, Spain )$

Use of Daratumumab, a CD38 monoclonal antibody, in advanced multiple myeloma

Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan...

Use of Daratumumab, a CD38 monoclonal antibody, in advanced multiple myeloma ( Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )

Targeting JAK-STAT pathway in malignant and non-malignant cells in...

Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA

Targeting JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms ( Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA )

Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic...

Dr Valentin Goede - University Hospital of Cologne, Germany

Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic leukaemia ( Dr Valentin Goede - University Hospital of Cologne, Germany )

Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma

Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan...

Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma ( Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )

Vemurafenib and ipilimumab for metastatic melanoma

Dr Caroline Robert - Institute Gustave Roussy, Paris, France

Vemurafenib and ipilimumab for metastatic melanoma ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France )

Phase I study measures effect of ipilimumab and nivolumab combination in...

Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA

Phase I study measures effect of ipilimumab and nivolumab combination in melanoma patients ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )

Comment on progression free survival in lung cancer patients and the GALAXY-1...

Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA

Comment on progression free survival in lung cancer patients and the GALAXY-1 trial ( Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA )

More from ecancer